Anyone can get sickle cell disease — the only requirement is inheriting two copies of the abnormal hemoglobin gene, one from each parent. It is not a “Black disease,” an “African disease,” or a disease of any single race. It is a genetic disease, and genes cross borders.
That said, the gene is far more common in people whose ancestors came from regions where malaria was endemic: sub-Saharan Africa, the Mediterranean (Greece, Italy, Turkey), the Middle East, India, and parts of Central and South America. In the United States, sickle cell disease affects roughly 1 in every 365 Black or African American births and about 1 in 16,300 Hispanic American births — but White, South Asian, and mixed-ancestry patients are diagnosed every year, and they are frequently diagnosed late because no one thought to look.
The Genetics: Why Two Genes Matter
Sickle cell disease comes from a single-letter change in the HBB gene on chromosome 11. That change swaps glutamic acid for valine at position 6 of the beta-globin chain, producing hemoglobin S (HbS).
When HbS gives up its oxygen, the molecules stack into rigid polymers that deform the red cell into a crescent or “sickle” shape. Those stiff cells jam capillaries, cause pain, and rupture early — surviving only 10 to 20 days instead of the roughly 120-day lifespan of normal red blood cells. That shortened survival is what drives the chronic hemolytic anemia.
The disease is autosomal recessive. One abnormal gene gives you sickle cell trait — usually symptom-free but passable to your children. Two abnormal genes give you disease. You can read more about how the sickle mutation arose and spread in our deeper genetics piece.
Inheritance Odds at a Glance
| Parent 1 | Parent 2 | Chance of Disease | Chance of Trait | Chance Unaffected |
|---|---|---|---|---|
| Trait (AS) | Trait (AS) | 25% | 50% | 25% |
| Trait (AS) | Normal (AA) | 0% | 50% | 50% |
| Disease (SS) | Trait (AS) | 50% | 50% | 0% |
| Disease (SS) | Normal (AA) | 0% | 100% | 0% |
| Trait (AS) | Beta-thal trait | 25% (HbS β-thal) | 50% | 25% |
Each pregnancy is an independent roll of the dice. Two carrier parents with three healthy children still face a 25% risk with the fourth.
Not All Sickle Cell Disease Is the Same
“Sickle cell disease” is an umbrella term covering several genotypes. Severity varies considerably between them, which matters for prognosis and counseling.
| Genotype | What Was Inherited | Typical Severity |
|---|---|---|
| HbSS (sickle cell anemia) | Two HbS genes | Most severe; baseline Hb often 6–9 g/dL |
| HbSC | One HbS + one HbC | Moderate; more retinopathy and bone infarcts |
| HbS β⁰-thalassemia | HbS + no beta chain production | Similar to HbSS |
| HbS β⁺-thalassemia | HbS + reduced beta chain production | Mild to moderate |
| HbAS (trait) | One HbS gene only | Not a disease; rare risk under extreme conditions |
Sickle cell sits within the broader family of red blood cell disorders, alongside thalassemias and enzyme deficiencies that can coexist and complicate the clinical picture.
Symptoms: What Patients Actually Experience
Babies are usually well for the first 4–6 months because fetal hemoglobin (HbF) protects them. As HbF falls, symptoms appear.
- Vaso-occlusive pain crises — deep bone, chest, back, or abdominal pain lasting hours to days; the leading reason for hospitalization
- Dactylitis — painful swelling of hands and feet, often the first sign in infants
- Chronic anemia — fatigue, pallor, jaundice, scleral icterus
- Infections — the spleen self-destructs early, raising risk from pneumococcus and other encapsulated bacteria
- Delayed growth and puberty
Serious complications include acute chest syndrome (fever, chest pain, new lung infiltrate — a medical emergency), stroke, priapism, leg ulcers, avascular necrosis of the hip, proliferative retinopathy, and progressive kidney disease.
How It’s Diagnosed
All 50 US states screen every newborn for sickle cell disease. A heel-stick blood sample is tested by isoelectric focusing or HPLC, and abnormal results trigger confirmatory testing — typically hemoglobin electrophoresis or HPLC with quantification, sometimes plus DNA analysis.
Older children, adults, and immigrants who missed screening can be tested at any time with the same panel plus a CBC and reticulocyte count. Our guide to the diagnosis of sickle cell disease walks through the workup in detail.
Typical Lab Pattern in HbSS
| Test | Normal | Typical in Sickle Cell Anemia |
|---|---|---|
| Hemoglobin | 12–16 g/dL | 6–9 g/dL |
| Reticulocyte count | 0.5–1.5% | 3–15% (elevated) |
| Hemoglobin S on electrophoresis | 0% | >80–90% |
| Hemoglobin A | 95–98% | 0% (HbSS) |
| Total bilirubin | <1.2 mg/dL | Elevated (indirect) |
| LDH | Normal | Elevated |
Treatment: More Options Than Ever
- Hydroxyurea — raises fetal hemoglobin, reducing pain crises, acute chest syndrome, and transfusion need. The backbone of therapy.
- Penicillin prophylaxis — twice daily from roughly 2 months through age 5, plus full pneumococcal and meningococcal vaccination.
- Transcranial Doppler screening — annually from ages 2 to 16 to identify children at high stroke risk, who then benefit from chronic transfusion.
- Transfusion programs — with iron chelation to prevent overload.
- L-glutamine and crizanlizumab — newer agents that reduce crisis frequency in selected patients.
- Folic acid — supports the high red cell turnover.
- Stem cell transplant and gene therapy — the only curative options. Transplant from a matched sibling has the best track record; FDA-approved gene therapies became available in late 2023. Both depend on healthy bone marrow function being restored after conditioning.
When to See a Doctor
Go to the emergency department immediately for:
- Fever of 101°F (38.5°C) or higher — in sickle cell disease this is a sepsis rule-out, not a wait-and-see
- Chest pain, shortness of breath, or low oxygen saturation
- Sudden weakness, facial droop, slurred speech, or severe headache
- Pain not controlled by your home regimen
- Priapism lasting more than 2 hours
- Sudden abdominal swelling or worsening pallor (splenic sequestration)
Schedule non-urgent testing if you’re planning a pregnancy, have a family member with trait or disease, or come from an at-risk ancestral background and have never been screened.
Frequently Asked Questions
Can White people get sickle cell disease?
Yes. HbS is common around the Mediterranean basin and in parts of the Middle East and India. Patients of Greek, Italian, Turkish, Arab, and South Asian ancestry are diagnosed regularly, and delayed diagnosis is more common in them simply because clinicians don’t suspect it.
Can you develop sickle cell disease later in life?
No. You either inherit the two genes at conception or you don’t. What can happen is late diagnosis — a person with a milder genotype like HbSC or HbS β⁺-thalassemia may reach adulthood before anyone identifies the cause of their anemia or joint pain.
Is sickle cell trait harmful?
For nearly everyone, no. Carriers have normal hemoglobin and life expectancy. Under extreme conditions — intense exertion at altitude, severe dehydration — rare complications such as exertional rhabdomyolysis or splenic infarction have been reported. Trait also carries a small increase in risk of renal medullary carcinoma and painless hematuria.
If both parents have trait, will a child definitely be affected?
No — there is a 25% chance per pregnancy of disease, 50% of trait, and 25% of inheriting neither abnormal gene.
What is the life expectancy today?
It has improved dramatically. With newborn screening, penicillin prophylaxis, vaccination, hydroxyurea, and stroke screening, most patients in high-income countries now live into their 40s, 50s, and beyond — compared with a median survival of about 14 years in the 1970s.
Key Takeaways
- Sickle cell disease requires two abnormal hemoglobin genes — ancestry raises the odds, but it does not determine them.
- Two carrier parents face a 25% risk of an affected child with every pregnancy.
- Know your status before starting a family; a hemoglobin electrophoresis is cheap, fast, and definitive.
- Fever is an emergency. Hydroxyurea, vaccines, and annual transcranial Doppler in children prevent the worst outcomes.
This article is for education and does not replace individualized medical advice. Discuss testing, counseling, and treatment decisions with your hematologist or primary care clinician.
